Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-048395
Filing Date
2023-02-24
Accepted
2023-02-24 13:10:04
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d465041d424b5.htm 424B5 484643
2 EX-FILING FEES d465041dexfilingfees.htm EX-FILING FEES 46833
3 GRAPHIC g465041g88f87.jpg GRAPHIC 30115
4 GRAPHIC g465041g88f88.jpg GRAPHIC 32531
5 GRAPHIC g469432g45q45.jpg GRAPHIC 31177
  Complete submission text file 0001193125-23-048395.txt   650690
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269899 | Film No.: 23665342
SIC: 2834 Pharmaceutical Preparations